Protara Therapeutics, Inc. short interest in 2025
In 2025, Protara Therapeutics, Inc.'s disclosed short interest ran from 21.35% of shares outstanding on 15 Jan 2025 to 5.70% on 31 Dec 2025, a change of -15.65 percentage points. The year's high was 21.35% on 15 Jan 2025 and its low 5.66% on 30 May 2025, averaging 9.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.66 days on 29 Aug 2025. Full history: Protara Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 21.35% (15 Jan 2025)
- End of year
- 5.70% (31 Dec 2025)
- Change
- -15.65 pp
- High
- 21.35% (15 Jan 2025)
- Low
- 5.66% (30 May 2025)
- Average
- 9.44%
- Highest days to cover
- 20.66 (29 Aug 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 21.35% | 10.17 | |
| 31 Jan 2025 | 20.34% | 15.02 | |
| 14 Feb 2025 | 20.13% | 17.79 | |
| 28 Feb 2025 | 14.39% | 8.29 | |
| 14 Mar 2025 | 8.63% | 8.13 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 10.10% | 9.22 | |
| 15 Apr 2025 | 9.83% | 7.06 | |
| 30 Apr 2025 | 12.00% | 3.26 | |
| 15 May 2025 | 5.83% | 7.30 | 10-Q filed, results (8-K) |
| 30 May 2025 | 5.66% | 7.21 | |
| 13 Jun 2025 | 5.71% | 9.05 | |
| 30 Jun 2025 | 7.32% | 3.99 | |
| 15 Jul 2025 | 7.49% | 11.40 | |
| 31 Jul 2025 | 7.60% | 14.03 | |
| 15 Aug 2025 | 7.19% | 14.13 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 7.74% | 20.66 | |
| 15 Sep 2025 | 6.98% | 18.47 | |
| 30 Sep 2025 | 6.38% | 2.51 | |
| 15 Oct 2025 | 7.40% | 4.50 | |
| 31 Oct 2025 | 7.32% | 8.27 | |
| 14 Nov 2025 | 7.19% | 6.51 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 7.54% | 3.12 | |
| 15 Dec 2025 | 6.74% | 1.68 | |
| 31 Dec 2025 | 5.70% | 3.95 |
See also: Protara Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.